In reply to Li et al. Letter to the editor. "Once daily (OD) versus twice-daily (BID) chemoradiation for limited stage small cell lung cancer (LS-SCLC): A meta-analysis of randomized clinical trials.".

Radiother Oncol

Latin America Cooperative Oncology Group (LACOG), Porto Alegre, Brazil; Department of Oncology - Division of Radiation Oncology, Kingston General Hospital, Queen's University, Kingston, ON, Canada.

Published: December 2022

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.radonc.2022.09.017DOI Listing

Publication Analysis

Top Keywords

reply letter
4
letter editor
4
editor "once
4
"once daily
4
daily versus
4
versus twice-daily
4
twice-daily bid
4
bid chemoradiation
4
chemoradiation limited
4
limited stage
4

Similar Publications

Reply to Wang et al.

Gastroenterology

January 2025

Department of Medicine, Section of Medical Oncology, Yale School of Medicine, New Haven, USA. Electronic address:

View Article and Find Full Text PDF

Author Reply.

BJOG

January 2025

Department of Women's and Children's Health, Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, UK.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!